Triochem Products posts ₹797 lakh profit on asset sale gain

3 min read     Updated on 30 Jul 2026, 06:24 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Triochem Products Limited posted a net profit of ₹797.07 lakh in FY26, reversing a prior-year loss, primarily due to a ₹1,116.65 lakh gain from the sale of immovable properties and plant machinery. Operating revenue was nil, and EBITDA losses widened to ₹60.19 lakh. The company remains debt-free with strong liquidity of ₹1,961.73 lakh. The upcoming AGM on August 22, 2026, will address the re-appointment of director Shyam Sundar Sharma.

powered bylight_fuzz_icon
46960991

*this image is generated using AI for illustrative purposes only.

Triochem Products Limited reported a net profit of ₹797.07 lakh for the financial year ended March 31, 2026 (FY26), reversing a net loss of ₹40.01 lakh in FY25. The turnaround was driven entirely by an exceptional gain of ₹1,116.65 lakh from the sale of immovable properties, plant, and machinery. Operating revenue remained at nil as the company had no manufacturing activities during the period, signaling that the bottom-line improvement is non-operational. Shareholders will vote on the adoption of these financials and the re-appointment of a director at the 54th Annual General Meeting (AGM) on August 22, 2026.

The Board of Directors convened the AGM at its registered office in Mumbai to transact ordinary and special business. Key agenda items include the re-appointment of Mr. Shyam Sundar Sharma as a Non-Executive, Non-Independent Director. Mr. Sharma, aged 79, retires by rotation but is eligible for re-appointment under Regulation 17(1A) of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, which mandates a special resolution for directors over the age of 75. The register of members will remain closed from August 16, 2026, to August 22, 2026.

The asset sales were executed in multiple tranches between January 19, 2026, and February 5, 2026, following shareholder approval via postal ballot on December 13, 2025. The transaction was classified as a Material Related Party Transaction under Section 188 of the Companies Act, 2013, and Regulation 23 of the SEBI LODR Regulations, 2015. An independent registered valuer certified the fair market value at approximately ₹672.05 lakh for property, plant, and machinery, and ₹501.15 lakh (net of transfer expenses) for investment properties. The assets sold had an aggregate written-down value (WDV) of ₹56.92 lakh.

Financial Performance Overview

Metric FY26 FY25 Change
Revenue from Operations ₹ Nil ₹ Nil
Other Income ₹86.45 lakh ₹105.01 lakh -17.7%
EBITDA (₹60.19 lakh) (₹16.94 lakh) Widened
Exceptional Items ₹1,116.65 lakh ₹ Nil New
Profit Before Tax ₹1,051.80 lakh (₹24.62 lakh) Turnaround
Net Profit After Tax ₹797.07 lakh (₹40.01 lakh) Turnaround

The company’s total income stood at ₹86.45 lakh, derived solely from other income, which declined from ₹105.01 lakh in the previous year. Earnings before interest, taxes, depreciation, and amortization (EBITDA) widened to a loss of ₹60.19 lakh from ₹16.94 lakh, reflecting ongoing operational costs without corresponding revenue generation. The profit before tax surged to ₹1,051.80 lakh, aided by the exceptional gain, while tax expense amounted to ₹254.73 lakh.

What the Numbers Show

The financial results reveal a complete disconnect between operational performance and profitability. With zero revenue from operations and a widening EBITDA loss, the company’s core business activities are currently dormant. The reported net profit is entirely attributable to the one-time monetization of non-core assets. This suggests that while the balance sheet has been strengthened with cash proceeds from the asset sales, there is no underlying operational cash flow to sustain earnings. Investors should note that the liquidity position is supported by these proceeds, which management intends to use for new business ventures, but no new revenue streams have been established yet.

The company remains debt-free, with no borrowings or term loans outstanding. As of March 31, 2026, it held cash and cash equivalents along with other liquid investments aggregating approximately ₹1,961.73 lakh. The paid-up equity share capital remained unchanged at ₹24.50 lakh, comprising 2,45,000 equity shares of ₹10 each. No dividend was declared for FY26, consistent with the lack of operational profits. Statutory auditors Kanu Doshi Associates LLP issued an unqualified opinion, confirming that the financial statements present a true and fair view of the company’s state of affairs.

Historical Stock Returns for Triochem Products

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%0.0%0.0%0.0%0.0%

What specific new business ventures does management plan to initiate with the ₹19.6 crore cash reserves, and what is the expected timeline for generating operational revenue?

How will the re-appointment of Mr. Shyam Sundar Sharma, who is over 75, influence the company's strategic direction and governance stability in the near term?

Given the complete cessation of manufacturing activities, are there any regulatory or compliance risks associated with maintaining listing status without core operations?

Triochem FY26 profit surges on asset sale gain

1 min read     Updated on 29 May 2026, 11:09 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Triochem Products Limited reported a net profit of ₹797.07 lakh for the financial year ended March 31, 2026, reversing previous year trends, primarily due to an exceptional gain of ₹1,116.65 lakh from the sale of non-core assets. The Board approved the audited financial results, Directors' Report, and fixed the 54th AGM for August 22, 2026, while also appointing internal auditors for the upcoming fiscal year.

powered bylight_fuzz_icon
41012472

*this image is generated using AI for illustrative purposes only.

Triochem Products Limited reported a net profit of ₹797.07 lakh for the financial year ended March 31, 2026, a significant turnaround driven by the sale of non-core assets. The company recorded an exceptional gain of ₹1,116.65 lakh during the quarter from the sale of immovable properties, plant & machinery, and investment properties. The Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026, at its meeting held on May 29, 2026.

The exceptional item arose from the monetization of assets with an aggregate Written Down Value (WDV) of ₹56.92 lakhs. The fair market value of these assets, certified by an Independent Registered Valuer, was approximately ₹672.05 lakhs for property, plant & machinery and ₹501.15 lakhs for investment properties. The sale, completed in multiple tranches between January 19, 2026, and February 5, 2026, was undertaken on an arm's length basis. Proceeds from the cash transaction are proposed to be utilized for funding new business ventures and strategic initiatives.

For the quarter ended March 31, 2026, the company reported a net profit of ₹832.57 lakh, compared to a net loss of ₹45.18 lakh in the corresponding period of the previous year. Total income from operations for the year stood at ₹86.45 lakh, while total expenses were ₹151.30 lakh. The statutory auditors, M/s. Kanu Doshi Associates LLP, issued an unqualified report on the financial results.

The Board approved the Directors' Report and the Management Discussion & Analysis for FY26. Additionally, the Board fixed the 54th Annual General Meeting for Saturday, August 22, 2026, at the registered office in Mumbai. The Register of Members and Share Transfer Books will remain closed from August 16, 2026, to August 22, 2026.

Financial Metric Q4 FY26 (₹ in lakhs) FY26 (₹ in lakhs)
Total Income 12.77 86.45
Total Expenses 30.41 151.30
Exceptional Items 1,116.65 1,116.65
Net Profit 832.57 797.07
Basic EPS 339.83 325.34

The Board also approved the appointment of M/s. M. L. BHUWANIA AND CO LLP as Internal Auditors for the financial year 2026-27. Mr. Shyam Sundar Sharma, Non-Executive Director, retires by rotation at the ensuing AGM and is eligible for re-appointment.

Historical Stock Returns for Triochem Products

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%0.0%0.0%0.0%0.0%

What specific new business ventures and strategic initiatives will the proceeds from the asset sale fund?

How will Triochem Products sustain profitability in FY27 given that the recent turnaround was driven by one-time exceptional gains?

What are the management's targets for operational income growth to offset the current low revenue from operations?

More News on Triochem Products

1 Year Returns:0.00%